Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan Morning vs Evening vs Lisinopril in Hypertension with CV Risk Factors
NCT00241124Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in hypertension (HTN), sponsored by Novartis. Started Apr 2004; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00241124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241124.